F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,159 | -23,013 | -16,662 | -9,750 | -5,195 |
| Depreciation Amortization | 180 | 844 | 263 | 171 | 83 |
| Accounts payable and accrued liabilities | 1,497 | 2,260 | 1,106 | -155 | 106 |
| Other Working Capital | 2,850 | -8,505 | 999 | 305 | 121 |
| Other Operating Activity | 1,108 | 6,303 | -6,177 | -5,336 | -1,902 |
| Operating Cash Flow | $-1,524 | $-22,111 | $-20,471 | $-14,765 | $-6,787 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -208 | -205 | -71 |
| Net Acquisitions | N/A | 5,499 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -6,000 | -6,000 | N/A |
| Sale Of Investment | N/A | N/A | 26,767 | 16,787 | 8,884 |
| Purchase Sale Intangibles | -62 | -127 | N/A | N/A | N/A |
| Other Investing Activity | -62 | -127 | 0 | 0 | 0 |
| Investing Cash Flow | $-62 | $5,372 | $20,559 | $10,582 | $8,813 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 500 | 13,264 | 20,000 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 6 | 6 | N/A |
| Other Financing Activity | 0 | 0 | -447 | 0 | 0 |
| Financing Cash Flow | $500 | $13,264 | $19,559 | $6 | $N/A |
| Exchange Rate Effect | -267 | 180 | N/A | N/A | N/A |
| Beginning Cash Position | 4,901 | 8,196 | 14,958 | 14,958 | 14,958 |
| End Cash Position | 3,548 | 4,901 | 34,605 | 10,781 | 16,984 |
| Net Cash Flow | $-1,353 | $-3,295 | $19,647 | $-4,177 | $2,026 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,524 | -22,111 | -20,471 | -14,765 | -6,787 |
| Capital Expenditure | N/A | N/A | -208 | -205 | -71 |
| Free Cash Flow | -1,524 | -22,111 | -20,679 | -14,970 | -6,858 |